CME Group (NASDAQ:CME) Price Target Raised to $230.00

CME Group (NASDAQ:CME) had its target price upped by investment analysts at Bank of America from $226.00 to $230.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The brokerage currently has an “underperform” rating on the financial services provider’s stock. Bank of America‘s target price would suggest a potential downside of 9.27% from the stock’s previous close.

A number of other research firms have also commented on CME. Jefferies Financial Group reduced their target price on CME Group from $356.00 to $349.00 and set a “buy” rating for the company in a report on Thursday, April 9th. Piper Sandler dropped their price objective on CME Group from $329.00 to $295.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 15th. Keefe, Bruyette & Woods upgraded CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 price objective for the company in a report on Thursday, June 18th. Rothschild & Co Redburn upgraded shares of CME Group from a “neutral” rating to a “buy” rating and upped their target price for the company from $316.00 to $323.00 in a research note on Thursday, June 11th. Finally, Erste Group Bank downgraded shares of CME Group from a “buy” rating to a “hold” rating in a report on Friday, June 5th. Twelve investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $292.47.

CME Group Stock Up 1.7%

Shares of NASDAQ CME traded up $4.26 during midday trading on Thursday, hitting $253.50. The stock had a trading volume of 1,518,705 shares, compared to its average volume of 2,767,212. The business’s 50 day moving average is $255.87 and its 200-day moving average is $281.51. CME Group has a 52 week low of $218.31 and a 52 week high of $329.16. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The company has a market cap of $91.86 billion, a P/E ratio of 21.63, a PEG ratio of 2.95 and a beta of 0.25.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, beating the consensus estimate of $2.91 by $0.08. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The company had revenue of $1.71 billion during the quarter, compared to the consensus estimate of $1.68 billion. During the same quarter last year, the firm earned $2.96 earnings per share. The firm’s quarterly revenue was up .8% compared to the same quarter last year. As a group, analysts predict that CME Group will post 12.17 EPS for the current year.

Insider Activity at CME Group

In related news, CEO Terrence A. Duffy sold 35,000 shares of CME Group stock in a transaction that occurred on Friday, May 15th. The stock was sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the sale, the chief executive officer owned 55,630 shares of the company’s stock, valued at approximately $16,606,111.30. This trade represents a 38.62% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director William R. Shepard acquired 325 shares of the company’s stock in a transaction on Thursday, June 25th. The shares were bought at an average cost of $230.57 per share, with a total value of $74,935.25. Following the acquisition, the director directly owned 260,442 shares in the company, valued at approximately $60,050,111.94. The trade was a 0.12% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 0.30% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. Asset Dedication LLC grew its holdings in shares of CME Group by 64.9% in the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 37 shares in the last quarter. Whipplewood Advisors LLC lifted its position in CME Group by 2,075.0% during the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 83 shares during the last quarter. FNY Investment Advisers LLC purchased a new position in shares of CME Group in the 4th quarter worth $27,000. Elkhorn Partners Limited Partnership purchased a new position in shares of CME Group in the 4th quarter worth $27,000. Finally, Hilton Head Capital Partners LLC purchased a new position in shares of CME Group in the 4th quarter worth $28,000. 87.75% of the stock is currently owned by institutional investors.

Key Stories Impacting CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME Group reported Q2 EPS of $2.99, beating estimates, while revenue of about $1.71 billion also topped expectations, highlighting resilient demand in its derivatives business. CME profit tops estimates, CEO says ‘perps’ chatter overshadows results
• Positive Sentiment: Management said the first half of 2026 was the strongest in company history for revenue, adjusted operating income, adjusted net income, and adjusted diluted EPS, which supports the bullish reaction. CME Group jumps after Q2 earnings beat and strong trading activity
• Positive Sentiment: Trading activity remained robust, with average daily volume near record levels and market data revenue reaching a record, both of which suggest durable demand across CME’s platform. CME Group (CME) Q2 Earnings and Revenues Top Estimates
• Neutral Sentiment: Several analysts reiterated mixed views after earnings: UBS maintained a Hold with a $260 target, while Bank of America kept a Sell despite raising its target, suggesting the stock may still face valuation questions. Neutral Stance Reiterated on CME as Solid Fundamentals Meet Valuation Limits; $260 Price Target Maintained

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.